Oct 16, 2026 07:58AM
Oct 15, 2026 07:30AM
Oct 15, 2026 07:30AM
Jun 16, 2026 08:33AM
Apr 30, 2026 08:31AM
Apr 30, 2026 08:30AM
Apr 30, 2026 08:00AM BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
Apr 28, 2026 04:05PM
Feb 26, 2026 04:05PM
Feb 10, 2026 06:53AM
Feb 4, 2026 08:02AM
Feb 4, 2026 08:00AM
Oct 29, 2025 04:05PM
Sep 15, 2025 08:32AM Labcorp completes $225 million BioReference Health oncology assets deal
Sep 15, 2025 08:30AM
Jul 31, 2025 04:05PM
Jul 8, 2025 08:03AM
Jul 8, 2025 08:00AM
Jun 25, 2025 08:05AM
Jun 25, 2025 08:00AM
Mar 19, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Mar 17, 2025 08:01AM
Mar 17, 2025 08:00AM
Mar 11, 2025 07:07AM
Mar 11, 2025 07:00AM
Jan 27, 2025 08:00AM
Jan 8, 2025 09:27AM
Jan 7, 2025 08:00AM OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
Nov 8, 2024 04:05PM
Nov 7, 2024 08:00AM
Sep 25, 2024 08:31AM
Sep 25, 2024 08:30AM
Sep 16, 2024 07:30AM
Aug 9, 2024 04:05PM
Aug 7, 2024 04:06PM OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
May 7, 2024 04:05PM
Mar 28, 2024 08:01AM
Mar 28, 2024 08:00AM
Mar 20, 2024 08:00AM
Nov 2, 2023 10:00AM
Oct 25, 2023 04:25PM
Sep 12, 2023 08:31AM Entera Bio (ENTX) and OPKO Biologics (OPK) Collaborate to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
Sep 12, 2023 08:30AM
Aug 3, 2023 04:05PM
Jun 28, 2023 06:45AM
Jun 28, 2023 06:45AM
May 3, 2023 04:05PM
Mar 9, 2023 08:13AM
Mar 8, 2023 08:03AM OPKO Health's (OPK) ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Mar 8, 2023 08:00AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All